Cerulean Pharma reported $49.19M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adamis Pharmaceuticals ADMP:US 17.69M 12.85M
Agile Therapeutics AGRX:US $ 32.83M 3.53M
Arrowhead Research ARWR:US $ 751.78M 48.21M
Bayer BAYN:GR € 128794M 3012M
Biocept BIOC:US $ 61.94M 1.53M
Brainstorm Cell Therapeutics BCLI:US $ 18.96M 6.83M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Immunogen IMGN:US $ 422.3M 59.41M
Macrogenics MGNX:US $ 218.04M 53.4M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
YTE INCY:US $ 5319.04M 264.81M